Home
About
Overview
Sharing Data
ORCID
Help
History (20)
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP.
Value-Based Medicine and Integration of Tumor Biology.
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
Axl Regulation of NK Cell Activity Creates an Immunosuppressive Tumor Immune Microenvironment in Head and Neck Cancer.
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer.
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer. BMC Cancer. 2022 Apr 23; 22(1):447.
View in:
PubMed
subject areas
Cell Line, Tumor
Cetuximab
Drug Resistance, Neoplasm
ErbB Receptors
Head and Neck Neoplasms
Humans
Neuregulin-1
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
authors with profiles
Ravi Salgia